Changes in composition of caecal microbiota associated with increased colon inflammation in interleukin-10 gene-deficient mice inoculated with Enterococcus species

Nutrients

Volumn 7, Issue 3, 2015, Pages 1798-1816

  Bassett, Shalome A ^a,b   Young, Wayne ^a,b   Barnett, Matthew P G ^a,b,c   Cookson, Adrian L ^a,d   McNabb, Warren C ^a,b,d   Roy, Nicole C ^a,b,c,d  

^a AGRESEARCH GRASSLANDS   (New Zealand)

^b Nutrigenomics New Zealand   (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d MASSEY UNIVERSITY   (New Zealand)

Author keywords

Colitis; Crohn s disease; Gastrointestinal disease; Microbiome

Indexed keywords

INTERLEUKIN 10;

ANIMAL EXPERIMENT; ARTICLE; COLITIS; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DISEASE COURSE; DNA EXTRACTION; DYSBIOSIS; ENTEROCOCCUS; ESCHERICHIA; GENE EXPRESSION; GENOTYPE; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; INOCULATION; INTESTINE FLORA; MALE; MOUSE; NONHUMAN; PYROSEQUENCING; REAL TIME POLYMERASE CHAIN REACTION; SHIGELLA; ANIMAL; BACTERIUM; BIODIVERSITY; C57BL MOUSE; CECUM; GENETICS; INFLAMMATORY BOWEL DISEASES; KNOCKOUT MOUSE; METABOLISM; MICROBIOLOGY; MICROFLORA; PATHOLOGY;

ANIMALS; BACTERIA; BIODIVERSITY; CECUM; COLITIS; ENTEROCOCCUS; GENOTYPE; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-10; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROBIOTA;

EID: 84968724815     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7031798     Document Type: Article

References (44)

1. Conte, M.P.; Schippa, S.; Zamboni, I.; Penta, M.; Chiarini, F.; Seganti, L.; Osborn, J.; Falconieri, P.; Borrelli, O.; Cucchiara, S. Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut 2006, 55, 1760–1767.
2. Frank, D.N.; St Amand, A.L.; Feldman, R.A.; Boedeker, E.C.; Harpaz, N.; Pace, N.R. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. USA 2007, 104, 13780–13785.
3. Gueimonde, M.; Ouwehand, A.; Huhtinen, H.; Salminen, E.; Salminen, S. Qualitative and quantitative analyses of the bifidobacterial microbiota in the colonic mucosa of patients with colorectal cancer, diverticulitis and inflammatory bowel disease. World J. Gastroenterol. 2007, 13, 3985–3989.
4. Lepage, P.; Hösler, R.; Spehlmann, M.E.; Rehman, A.; Zvirbliene, A.; Begun, A.; Ott, S.; Kupcinskas, L.; Doré, J.; Raedler, A.; et al. Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. Gastroenterology 2011, 141, 227–236.
5. Noor, S.O.; Ridgway, K.; Scovell, L.; Kemsley, E.K.; Lund, E.K.; Jamieson, C.; Johnson, I.T.; Narbad, A. Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota. BMC Gastroenterol. 2010, 10, 134.
6. Ott, S.J.; Musfeldt, M.; Wenderoth, D.F.; Hampe, J.; Brant, O.; Fölsch, U.R.; Timmis, K.N.; Schreiber, S. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 2004, 53, 685–693.
7. Takaishi, H.; Matsuki, T.; Nakazawa, A.; Takada, T.; Kado, S.; Asahara, T.; Kamada, N.; Sakuraba, A.; Yajima, T.; Higuchi, H.; et al. Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease. Int. J. Med. Microbiol. 2008, 298, 463–472.
8. -/- mice. Infect. Immun. 2014, 82, 2239–2246.
9. Sartor, R.B.; Mazmanian, S.K. Intestinal Microbes in Inflammatory Bowel Diseases. Am. J. Gastroenterol. Suppl. 2012, 1, 15–21.
10. Frank, D.; Robertson, C.; Hamm, C.; Kpadeh, Z.; Zhang, T.; Chen, H.; Zhu, W.; Sartor, R.; Boedeker, E.; Harpaz, N.; et al. Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm. Bowel Dis. 2011, 17, 179–184.
11. Sellon, R.K.; Tonkonogy, S.; Schultz, M.; Dieleman, L.A.; Grenther, W.; Balish, E.; Rennick, D.M.; Sartor, R.B. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun. 1998, 66, 5224–5231.
12. Kuhn, R.; Lohler, J.; Rennick, D.; Rajewsky, K.; Muller, W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993, 75, 263–274.
13. Balish, E.; Warner, T. Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. Am. J. Pathol. 2002, 160, 2253–2257.
14. Kim, S.C.; Tonkonogy, S.L.; Albright, C.A.; Tsang, J.; Balish, E.J.; Braun, J.; Huycke, M.M.; Sartor, R.B. Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology 2005, 128, 891–906.
15. Kim, S.C.; Tonkonogy, S.L.; Karrasch, T.; Jobin, C.; Sartor, R.B. Dual-association of gnotobiotic IL-10-/- mice with 2 nonpathogenic commensal bacteria induces aggressive pancolitis. Inflamm. Bowel Dis. 2007, 13, 1457–1466.
16. Eaton, T.J.; Gasson, M.J. Molecular screening of Enterococcus virulence determinants and potential for genetic exchange between food and medical isolates. Appl. Environ. Microbiol. 2001, 67, 1628–1635.
17. Jett, B.D.; Huycke, M.M.; Gilmore, M.S. Virulence of enterococci. Clin. Microbiol. Rev. 1994, 7, 462–478.
18. Finegold, S.M.; Sutter, V.L.; Mathisen, G.E. Normal indigenous intestinal flora. In Human Intestinal Microflora in Health and Disease; Hentges, D.J., Ed.; Academic Press: New York, NY, USA, 1983; pp. 3–31.
19. Tannock, G.W.; Cook, G. Enterococci as members of the intestinal microflora of humans. In The Enterococci: Pathogenesis, Molecular Biology, and Antibiotic Resistance; Gilmore, M.S., Clewell, D.B., Courvalin, P.M., Dunny, G.M., Murray, B.E., Rice, L.B., Eds.; ASM Press: Washington DC, USA, 2002.
20. Barnett, M.P.; McNabb, W.C.; Cookson, A.L.; Zhu, S.; Davy, M.; Knoch, B.; Nones, K.; Hodgkinson, A.J.; Roy, N.C. Changes in colon gene expression associated with increased colon inflammation in interleukin-10 gene-deficient mice inoculated with Enterococcus species. BMC Immunol. 2010, 11, 39.
21. Roy, N.C.; Barnett, M.P.G.; Knoch, B.; Dommels, Y.E.M.; McNabb, W.C. Nutrigenomics applied to an animal model of Inflammatory Bowel Diseases: Transcriptomic analysis of the effects of eicosapentaenoic acid- and arachidonic acid-enriched diets. Mutat. Res. 2007, 622, 103–116.
22. Bibiloni, R.; Simon, M.; Albright, C.A.; Sartor, B.; Tannock, G. Analysis of the large bowel microbiota of colitic mice using PCR/DGGE. Lett. Appl. Microbiol. 2005, 41, 45–51.
23. Laboratory, T.J. Overview of the Jackson Laboratory Facility Barrier Levels. Available online: http://jaxmice.jax.org/health/barrier.html (accessed on 16 December 2014).
24. Knoch, B.; Barnett, M.P.; Cooney, J.; McNabb, W.C.; Barraclough, D.; Laing, W.; Zhu, S.; Park, Z.A.; Maclean, P.; Knowles, S.O.; et al. Molecular characterization of the onset and progression of colitis in inoculated interleukin-10 gene-deficient mice: A role for PPARalpha. PPAR Res. 2010, 2010, doi:10.1155/2010/621069.
25. Knoch, B.; Barnett, M.P.; McNabb, W.C.; Zhu, S.; Park, Z.A.; Khan, A.; Roy, N.C. Dietary arachidonic acid-mediated effects on colon inflammation using transcriptome analysis. Mol. Nutr. Food. Res. 2010, 54 (Suppl 1), S62–74.
26. Knoch, B.; Barnett, M.P.G.; Zhu, S.T.; Park, Z.A.; Nones, K.; Dommels, Y.E.M.; Knowles, S.O.; McNabb, W.C.; Roy, N.C. Genome-wide analysis of dietary eicosapentaenoic acid- and oleic acid-induced modulation of colon inflammation in interleukin-10 gene-deficient mice. J. Nutrigenet. Nutrigenomics 2009, 2, 9–28.
27. Russ, A.E.; Peters, J.S.; McNabb, W.C.; Barnett, M.P.G.; Anderson, R.C.; Park, Z.; Zhu, S.T.; Maclean, P.; Reynolds, G.W.; Roy, N.C. Gene expression changes in the colon epithelium are similar to those of intact colon in the interleukin-10 gene deficient mouse in late inflammation. PloS One 2013, 8, e63251.
28. Knoch, B.; Nones, K.; Barnett, M.P.; McNabb, W.C.; Roy, N.C. Diversity of caecal bacteria is altered in interleukin-10 gene-deficient mice before and after colitis onset and when fed polyunsaturated fatty acids. Microbiology 2010, 156, 3306–3316.
29. Claus, S.P.; Ellero, S.L.; Berger, B.; Krause, L.; Bruttin, A.; Molina, J.; Paris, A.; Want, E.J.; de Waziers, I.; Cloarec, O.; et al. Colonization-induced host-gut microbial metabolic interaction. MBio 2011, 2, e00271–00210.
30. Caporaso, J.G.; Kuczynski, J.; Stombaugh, J.; Bittinger, K.; Bushman, F.D.; Costello, E.K.; Fierer, N.; Pena, A.G.; Goodrich, J.K.; Gordon, J.I.; et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 2010, 7, 335–336.
31. R Core Team. R: A language and Environment for Statistical Computing; R Foundation for Statistical Computing: Vienna, Austria, 2010.
32. De Mendiburu, F. Agricolae: Statistical Procedures for Agricultural Research. Available online: http://CRAN.R-project.org/package=agricolae (accessed on 3 February 2014).
33. Tannock, G.W.; Munro, K.; Harmsen, H.J.; Welling, G.W.; Smart, J.; Gopal, P.K. Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. Appl. Environ. Microbiol. 2000, 66, 2578–2588.
34. -/-) mice have an altered caecal microbiota that precedes the onset of intestinal inflammation. J. Appl. Microbiol. 2009, 107, 557–566.
35. Oksanen, J.; Blanchet, F.G.; Kindt, R.; Legendre, P.; Minchin, P.R.; O’Hara, R.B.; Simpson, G.L.; Solymos, P.; Stevens, M.H.H.; Wagner, H. Vegan: Community Ecology Package. Available online: http://CRAN.R-project.org/package=vegan (accessed on 3 February 2014).
36. Bakken, J.S.; Borody, T.; Brandt, L.J.; Brill, J.V.; Demarco, D.C.; Franzos, M.A.; Kelly, C.; Khoruts, A.; Louie, T.; Martinelli, L.P.; et al. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin. Gastroenterol. Hepatol. 2011, 9, 1044–1049.
37. Maharshak, N.; Packey, C.D.; Ellermann, M.; Manick, S.; Siddle, J.P.; Huh, E.Y.; Plevy, S.; Sartor, R.B.; Carroll, I.M. Altered enteric microbiota ecology in interleukin 10-deficient mice during development and progression of intestinal inflammation. Gut Microbes 2013, 4, 316–324.
38. Winter, S.E.; Winter, M.G.; Xavier, M.N.; Thiennimitr, P.; Poon, V.; Keestra, A.M.; Laughlin, R.C.; Gomez, G.; Wu, J.; Lawhon, S.D.; et al. Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science 2013, 339, 708–711.
39. Morgan, X.C.; Tickle, T.L.; Sokol, H.; Gevers, D.; Devaney, K.L.; Ward, D.V.; Reyes, J.A.; Shah, S.A.; LeLeiko, N.; Snapper, S.B.; et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012, 13, doi:10.1186/gb-2012-13-9-r79.
40. Yang, I.; Eibach, D.; Kops, F.; Brenneke, B.; Woltemate, S.; Schulze, J.; Bleich, A.; Gruber, A.D.; Muthupalani, S.; Fox, J.G.; Josenhans, C.; et al. Intestinal microbiota composition of interleukin-10 deficient C57BL/6J mice and susceptibility to Helicobacter hepaticus-induced colitis. PLoS One 2013, 8, e70783.
41. Manichanh, C.; Rigottier-Gois, L.; Bonnaud, E.; Gloux, K.; Pelletier, E.; Frangeul, L.; Nalin, R.; Jarrin, C.; Chardon, P.; Marteau, P.; et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006, 55, 205–211.
42. Lapthorne, S.; Pereira-Fantini, P.M.; Fouhy, F.; Wilson, G.; Thomas, S.L.; Dellios, N.L.; Scurr, M.; O'Sullivan, O.; Ross, R.P.; Stanton, C.; et al. Gut microbial diversity is reduced and is associated with colonic inflammation in a piglet model of short bowel syndrome. Gut Microbes 2013, 4, 212–221.
43. Swidsinski, A.; Loening-Baucke, V.; Vaneechoutte, M.; Doerffel, Y. Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora. Inflamm. Bowel Dis. 2008, 14, 147–161.
44. Ng, K.M.; Ferreyra, J.A.; Higginbottom, S.K.; Lynch, J.B.; Kashyap, P.C.; Gopinath, S.; Naidu, N.; Choudhury, B.; Weimer, B.C.; Monack, D.M.; et al. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 2013, 502, 96–99.